Mechanism of transcription-associated genome instability
转录相关基因组不稳定的机制
基本信息
- 批准号:10474278
- 负责人:
- 金额:$ 38.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-01 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdverse eventAnimal ModelBindingCell CycleCell physiologyCellsChromosomal RearrangementChromosomesComplexDNADNA DamageDNA RepairDNA StructureDNA biosynthesisDNA-Binding ProteinsDNA-Directed DNA PolymeraseDNA-Directed RNA PolymeraseDevelopmentDiseaseEventFrequenciesG-QuartetsG1 PhaseG2 PhaseGenesGenetic RecombinationGenetic TranscriptionGenomeGenomic InstabilityGoalsIn VitroInvestigationKnowledgeLinkMalignant NeoplasmsMissionModelingMutagenesisMutationNucleosidesProcessProteinsPublic HealthResearchRibonucleotidesSaccharomyces cerevisiaeStressStructureSystemTestingTopoisomeraseTorsionTranscription ProcessTranscriptional ActivationUnited States National Institutes of HealthUracilWorkcancer therapydensitygenetic approachgenome integritygraspin vivoinnovationmetaplastic cell transformationnovelprogramsprotein complexresponsetumorigenesis
项目摘要
PROJECT SUMMARY: Changes in the genome such as mutagenesis, duplication, deletions, and
recombination bring about somatic diseases like cancer and drive evolutionary processes. My lab has been
focused on understanding how such genome instability events occur at incongruently higher frequencies at
certain “hotspots.” Quite different from the familiar depiction of chromosomes as stationary strings made up of
DNA, genome is more like a busy highway, where many proteins, including topoisomerases in surveillance for
irregular helical torsion, bind and/or actively modify DNA. Moreover, mega-complexes of proteins like RNA
polymerase and DNA polymerase complexes are dynamically moving along, unwinding, and forcibly distorting
DNA while carrying out transcription and replication, sometimes physically colliding with each other. In order to
explain why mutation/recombination hotspots are often located within actively transcribed regions, we viewed
the multiple DNA-involving processes as an interactive system rather than as each independent activity and
identified transcription-associated causes of genome instability. My work was instrumental in showing that
mutations resulting from the non-canonical residues, uracil and ribonucleotide, are highly elevated upon
transcription activation. Subsequently, novel discoveries in my lab led to the model that non-replicative DNA
synthesis occurring in G1- and G2-phases of the cell cycles results in higher uracil density in actively
transcribed genes. We also made key findings linking the transcription-generated negative torsional stress with
the elevated recombination associated with the DNA secondary structure G-quadruplex or G4 DNA. We further
identified G4 DNA-binding proteins that either suppress or exacerbate such G4 DNA-induced genome
instability. The central goal of my research program is to uncover fundamental and conserved mechanism
underlying mutagenesis and genome rearrangements, which will be important for both the cellular
transformation into cancers and responses to chemotherapeutics. Building upon our previous findings, we will
continue to address important remaining questions by (1) using tractable genetic approaches to study
transcription-associated genome instability in the simple eukaryotic model organism Saccharomyces
cerevisiae, (2) developing innovative approaches to test the model of uracil/ribonucleotide incorporation into
DNA during G1 and G2, and (3) defining the functional and structural interaction between key G4 DNA-binding
proteins and G4 DNA both in vitro and in vivo.
Our ongoing investigation should further the understanding of how transcription, replication, and DNA
repair work in conjunction either for the benefit or the detriment of genome integrity. Having a comprehensive
picture of these interconnected and dynamic processes occurring on the genome will help in predicting how to
suppress and correct genome instability events adverse to normal cellular functions.
项目概述:基因组的变化,如突变、重复、缺失和
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nayun Kim其他文献
Nayun Kim的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nayun Kim', 18)}}的其他基金
Mechanism of transcription-associated genome instability
转录相关基因组不稳定的机制
- 批准号:
10592934 - 财政年份:2021
- 资助金额:
$ 38.71万 - 项目类别:
The Dimeric Dutpase of Trypanosoma brucei as a therapeutic target
布氏锥虫二聚体脱氨酶作为治疗靶点
- 批准号:
10362613 - 财政年份:2021
- 资助金额:
$ 38.71万 - 项目类别:
Mechanism of transcription-associated genome instability
转录相关基因组不稳定的机制
- 批准号:
10797547 - 财政年份:2021
- 资助金额:
$ 38.71万 - 项目类别:
Mechanism of transcription-associated genome instability
转录相关基因组不稳定的机制
- 批准号:
10207038 - 财政年份:2021
- 资助金额:
$ 38.71万 - 项目类别:
Mechanism of transcription-associated genome instability
转录相关基因组不稳定的机制
- 批准号:
10810267 - 财政年份:2021
- 资助金额:
$ 38.71万 - 项目类别:
Mechanism of transcription-associated genome instability
转录相关基因组不稳定的机制
- 批准号:
10649647 - 财政年份:2021
- 资助金额:
$ 38.71万 - 项目类别:
G-Quadruplex forming sequence motifs and genome instability
G-四链体形成序列基序和基因组不稳定性
- 批准号:
9889136 - 财政年份:2016
- 资助金额:
$ 38.71万 - 项目类别:
G-Quadruplex forming sequence motifs and genome instability
G-四链体形成序列基序和基因组不稳定性
- 批准号:
9103794 - 财政年份:2016
- 资助金额:
$ 38.71万 - 项目类别:
G-Quadruplex forming sequence motifs and genome instability
G-四链体形成序列基序和基因组不稳定性
- 批准号:
9247232 - 财政年份:2016
- 资助金额:
$ 38.71万 - 项目类别:
相似海外基金
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10707830 - 财政年份:2023
- 资助金额:
$ 38.71万 - 项目类别:
Hospital characteristics and Adverse event Rate Measurements (HARM) Evaluated over 21 years.
医院特征和不良事件发生率测量 (HARM) 经过 21 年的评估。
- 批准号:
479728 - 财政年份:2023
- 资助金额:
$ 38.71万 - 项目类别:
Operating Grants
Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV)
分析 ECOG-ACRIN 不良事件数据,以优化在不断发展的癌症治疗范式 (EVOLV) 背景下纵向耐受性评估的策略
- 批准号:
10884567 - 财政年份:2023
- 资助金额:
$ 38.71万 - 项目类别:
AE2Vec: Medical concept embedding and time-series analysis for automated adverse event detection
AE2Vec:用于自动不良事件检测的医学概念嵌入和时间序列分析
- 批准号:
10751964 - 财政年份:2023
- 资助金额:
$ 38.71万 - 项目类别:
Understanding the real-world adverse event risks of novel biosimilar drugs
了解新型生物仿制药的现实不良事件风险
- 批准号:
486321 - 财政年份:2022
- 资助金额:
$ 38.71万 - 项目类别:
Studentship Programs
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10676786 - 财政年份:2022
- 资助金额:
$ 38.71万 - 项目类别:
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10440970 - 财政年份:2022
- 资助金额:
$ 38.71万 - 项目类别:
Improving Adverse Event Reporting on Cooperative Oncology Group Trials
改进肿瘤学合作组试验的不良事件报告
- 批准号:
10642998 - 财政年份:2022
- 资助金额:
$ 38.71万 - 项目类别:
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10482465 - 财政年份:2022
- 资助金额:
$ 38.71万 - 项目类别:
Expanding and Scaling Two-way Texting to Reduce Unnecessary Follow-Up and Improve Adverse Event Identification Among Voluntary Medical Male Circumcision Clients in the Republic of South Africa
扩大和扩大双向短信,以减少南非共和国自愿医疗男性包皮环切术客户中不必要的后续行动并改善不良事件识别
- 批准号:
10191053 - 财政年份:2020
- 资助金额:
$ 38.71万 - 项目类别: